Evidence map›Paper›PMID 36287815›Full record

ArticleTomography (Ann Arbor, Mich.)2022

Structural and Functional Pulmonary Assessment in Severe COVID-19 Survivors at 12 Months after Discharge.

Andrea Corsi, Anna Caroli, Pietro Andrea Bonaffini, Caterina Conti, Alberto Arrigoni, Elisa Mercanzin, Gianluca Imeri, Marisa Anelli, Maurizio Balbi, Marina Pace and 4 more

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Scar wars: the viral menace.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Review
  14. Mechanisms of long COVID: An updated review.Chinese medical journal pulmonary and critical care medicine · 2023
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Andrea CorsiDepartment of Radiology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0003-3954-303X
Anna CaroliBioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.ORCID 0000-0002-4130-4663
Pietro Andrea BonaffiniDepartment of Radiology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0001-5335-9429
Caterina ContiRespiratory Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0002-1121-8908
Alberto ArrigoniBioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.ORCID 0000-0002-1914-6582
Elisa MercanzinDepartment of Radiology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0001-8326-2142
Gianluca ImeriRespiratory Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Marisa AnelliRespiratory Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Maurizio BalbiUnit of "Scienze Radiologiche", Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.ORCID 0000-0002-8436-3655
Marina PaceSchool of Medicine, University Milano Bicocca, 20126 Milan, Italy.
Adriana ZanolettiRespiratory Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Milena CapelliRespiratory Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Fabiano Di MarcoRespiratory Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Sandro SironiDepartment of Radiology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Ospedale Papa Giovanni XXIII · ITMario Negri Institute for Pharmacological Research · ITUniversity of Milan · ITUniversity of Bergamo · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term pulmonary sequelae in COVID-19 patients are currently under investigation worldwide. Potential relationships between blood sampling and functional and radiological findings are crucial to guide the follow-up. In this study, we collected and evaluated clinical status, namely symptoms and patients’ reported outcome, pulmonary function tests (PFT), laboratory tests, and radiological findings at 3- and 12-months post-discharge in patients admitted between 25 February and 2 May 2020, and who survived severe COVID-19 pneumonia. A history of chronic pulmonary disease or COVID-19-unrelated complications were used as exclusion criteria. Unenhanced CTs were analyzed quantitatively (compromising lung volume %) and qualitatively, with main patterns of: ground-glass opacity (GGO), consolidation, and reticular configuration. Patients were subsequently divided into groups based on their radiological trends and according to the evolution in the percentage of compromised lung volume. At 12 months post-discharge, seventy-one patients showed significantly improved laboratory tests and PFT. Among them, 63 patients also underwent CT examination: all patients with negative CT findings at three months (n = 14) had negative CT also at 12 months; among the 49/63 patients presenting CT alterations at three months, 1/49 (2%) normalized, 40/49 (82%) improved, 7/49 (14%) remained stably abnormal, and 1/49 (2%) worsened. D-dimer values were low in patients with normal CT and higher in cases with improved or stably abnormal CT (median values 213 vs. 329 vs. 1000 ng/mL, respectively). The overall compromised lung volume was reduced compared with three months post-discharge (12.3 vs. 14.4%, p < 0.001). In stably abnormal CT, the main pulmonary pattern changed, showing a reduction in GGO and an increase in reticular configuration. To summarize, PFT are normal in most COVID-19 survivors 12 months post-discharge, but CT structural abnormalities persist (although sensibly improved over time) and are associated with higher D-dimer values.

Indexed as

COVID-19Lung DiseasesAftercareHumansPatient DischargeSARS-CoV-2SurvivorsTomography, X-Ray ComputedCOVID-19lung diseasesrespiratory function testssevere acute respiratory syndrome coronavirus 2tomography

Identifiers

PMID36287815
PMCPMC9611724
OpenAlexW4306160121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.